NTC presenta exitos positivos del estudio de fase II Mirakle que evalúa un fármaco innovador para la conjuntivitis bacteriana MILÁN, 5 de diciembre de 2024 /PRNewswire/ — NTC, una compañía farmacéutica internacional centrada en I+D con sede en Italia, presenta exitos positivos del…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.